Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-01-29 @ 2:08 PM
Study NCT ID:
NCT01707004
Status:
COMPLETED
Last Update Posted:
2019-11-21
First Post:
2012-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
University of Wisconsin, Madison
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | View |
| None | Adult Acute Myeloid Leukemia in Remission | View |
| None | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | View |
| None | Adult Acute Myeloid Leukemia With Del(5q) | View |
| None | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | View |
| None | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | View |
| None | de Novo Myelodysplastic Syndromes | View |
| None | Previously Treated Myelodysplastic Syndromes | View |
| None | Recurrent Adult Acute Myeloid Leukemia | View |
| None | Secondary Acute Myeloid Leukemia | View |
Keywords: